Aspen Aerogels opened lower at $6.18, compared with its previous close of $6.41. In the last trading session, the stock traded between $5.96 and $6.58. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Aspen Aerogels is now worth
$ 10.57
Resulting in a loss of
$ 89.43 (89.43%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
66.67%
Hold
0%
Sell
33.33%
Markets Today
Today's Change
$-0.41 (-6.40%)
Day High
$6.58
Day Low
$5.96
Day Open
$6.18
Prev Close
$6.41
Volume
12,53,632
1W Return
25.03%
1M Return
10.27%
3M Return
-2.23%
6M Return
17.19%
1Y Return
65.75%
Fundamentals
Market Cap ($ Mn)
499
PE Ratio
-
PB Ratio
2.13
PEG Ratio
-
ROE
-109.45%
ROCE
-76.17%
EPS (TTM)
$-0.13
Investment Returns
1 Week
25.03%
1 Month
10.27%
3 Months
-2.23%
6 Months
17.19%
9 Months
70.94%
Financials
Quarterly
All values in $ Mn
78.0
Jun 25
73.0
Sep 25
41.3
Dec 25
37.9
Mar 26
49.8
Jun 26
85.2
Sep 26
Updates
6Nov
Aspen Aerogels files prospectus for $150M mixed shelf offering
Aspen Aerogels filed a prospectus for a $150 million mixed shelf offering. The registration allows issuance of various securities including stock and debt. The filing provides flexibility for opportunistic capital raising. No immediate securities were sold under this specific registration.
Adjusted EPS of $0.11 beat consensus estimate of $(0.08), driven by strong operational leverage. Revenue reached $85.178 million, up 16.66% YoY and exceeding guidance of $65-$80 million. Adjusted EBITDA hit $19.8 million, surpassing the guided range of $7-$15 million. European thermal barrier revenue set a record at $8 million, up 38% QoQ. Q4 guidance projects revenue of $60-$75 million and adjusted EBITDA of $5-$13 million.
7 days ago
6Oct
Aspen Aerogels Q2 revenue up 32% QoQ to $49.8 million
Q2 2026 revenue reached $49.8 million, up 32% QoQ. PyroThin thermal barrier business grew 81% sequentially. Q3 revenue guidance set at $65 million to $80 million. Adjusted EBITDA improved to -$6.6 million from -$12.7 million in Q1. European OEM revenue outlook raised to $20 million to $30 million.
